News and practice for haematology nurse specialists
The National Institute for Health and Care Excellence has recommended eculizumab (Soliris) for treating a rare life-threatening blood disorder called atypical Haemolytic Uraemic Syndrome (aHUS).
The National Institute for Health and Care Excellence has approved the anti-clotting drug dabigatran (Pradaxa) as an option for treating and preventing deep vein thrombosis and pulmonary embolism.
Latest research: haematology
Standardised aseptic technique training has improved nurses’ ability to prevent healthcare-associated infections in one hospital and led to better awareness of AT.
The number of patients with both type 2 diabetes and dementia is rising, which poses new challenges in blood glucose monitoring and medicines administration.
It seems the tide may be turning on the way older people are treated in the NHS, with the need to develop and improve this important area of care at last being acknowledged and acted on. There were two announcements this week that gave me hope that change is coming.
Behind the Headlines
“Patients with the highest genetic risk of suffering a heart attack benefit the most from cholesterol-lowering statin drugs,” The Guardian reports.
Looking for a new career?
Anaemia is often overlooked as its symptoms – shortness of breath, palpitations, headache and dizziness, for example – can be put down to a range of other conditions.